Trials / Terminated
TerminatedNCT01188915
Personalised Program for Women Treated for Hodgkin Disease
Personalised Program for Women Treated for Hodgkin Disease : Risk Evaluation of Breast Cancer and Intensive Screening Program for Women at High Risk of Breast Cancer. PROPER/IPC 2010-001
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
After treatment for Hodgkin disease, secondary cancer, in particular breast cancer induced by treatment, are the first cause of death. The investigators will estimate the risk to develop breast cancer in this population of women treated for hodgkin disease, and will propose women at high rish to participate in an intensive screening program based on an annual detection based on mammography, echography, and RMI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | intensive screening | Each year, women will have breast cancer detection based on mammography, echography and RMI. Questionaries will also be completed. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2016-09-01
- Completion
- 2026-07-01
- First posted
- 2010-08-26
- Last updated
- 2016-10-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01188915. Inclusion in this directory is not an endorsement.